2m 2m 2m 2m 2m 2m 2m
CAMP4 THERAP (CAMP)
NASDAQ
$3.89-$0.20 (-4.91%)
Price as of Nov 13, 2026 1:43 PM EST- $256.7MMarket Cap
- -4.22%1-Year Change
- BiotechnologyIndustry
CAMP4 THERAP (CAMP)
$3.89-$0.20 (-4.91%)
CAMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.09 | ||
Change | -$0.11 (-2.62%) | ||
Open | $4.19 | ||
High | $4.30 | ||
Low | $3.98 | ||
Previous Close | $4.20 | ||
Volume | 62,417 | ||
30-Day Average Volume | 141,532 | ||
1-Week Change | 9.95% | ||
1-Month Change | 11.75% | ||
1-Year Change | -4.22% | ||
3-Year Change | -42.25% | ||
5-Year Change | -98.22% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $134.0M | ||
Market Cap | $256.7M | ||
Enterprise Value | $132.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$29.0M | ||
Free Cash Flow | -$8.9M | ||
EBIT | -$29.0M | ||
EBITDA | -$28.4M | ||
Net Working Capital | $107.7M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 70 | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 23 | ||
Last Split Date | 02/02/2024 | ||
Earnings & Revenue